Design and Synthesis of Conformationally Constrained Analogs of 4-(3-Butoxy-4-methoxybenzyl) imidazolidin-2-one (Ro 20-1724) as Potent Inhibitors of cAMP- …

MF Brackeen, JA Stafford, DJ Cowan…

Index: Brackeen, Marcus F.; Cowan, David J.; Stafford, Jeffrey A.; Schoenen, Frank J.; Veal, James M.; et al. Journal of Medicinal Chemistry, 1995 , vol. 38, # 24 p. 4848 - 4854

Full Text: HTML

Citation Number: 45

Abstract

The synthesis and biological evaluation of CAMP-specific phosphodiesterase (PDE IV) inhibitors is described. The PDE IV inhibitor 4-(3-butoxy-4-methoxybenzyl) imidazolidin-2- one(Ro 20-1724, 2) was used as a template from which to design a set of rigid oxazolidinones, imidazolidinones, and pyrrolizidinones that mimic Ro 20-1724 but differ in the orientation of the carbonyl group. The endo isomer of each of these heterocycles was ...

Related Articles:

Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-asthmatics

[Kim, Euikyung; Chun, Hyung-Ok; Jung, Sung-Hak; Kim, Jong Hoon; Lee, Jae-Mok; Suh, Byung-Chul; Xiang, Myung Xik; Rhee, Chung K. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 14 p. 2355 - 2358]

Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding

[Bioorganic and Medicinal Chemistry Letters, , vol. 12, # 16 p. 2149 - 2152]

Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor

[Bioorganic and medicinal chemistry letters, , vol. 12, # 11 p. 1457 - 1461]

More Articles...